MarketPeel
Insider Trading Intelligence
Pricing
…
PM

Polly A. Murphy

CELC
DIRECTOR · CELCUITY INC. · CIK 0001829248
FILING MIX · LIFETIME76%/24%
BUYS
28
SELLS
9
TOTAL VALUE
$202.1K
COMPANIES
2
ACTIVE SINCE
Nov 2020
HOLDINGS NOW
14,048
AVG SELL PX
—
TRADE KIND
SHOWING 37 / 37
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Polly A. Murphy, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+50.00%+3.13%+1.86%+1.27%+1.27%—
14d2+50.00%-2.41%+1.74%-4.15%-4.15%—
30d2+50.00%+12.67%-2.53%+15.21%+15.21%—
60d2+50.00%-3.83%-2.56%-1.28%-1.28%—
90d2+50.00%+2.70%-0.88%+3.58%+3.58%—
180d2+50.00%-4.25%-6.69%+2.44%+2.44%—
1y2+50.00%-1.50%+0.29%-1.79%-1.79%—
2y2+50.00%-13.00%+29.51%-42.51%-42.51%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CELC · 14,048 shares · as of Jun 10, 2026
04,0758,15012,22516,3002023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 28 buys / 9 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AVIR
ATEA PHARMACEUTICALS, INC.
SALE
29,600——0Jun 18, 2026Jun 23, 2026 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
26,700——26,700Jun 18, 2026Jun 23, 2026 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
37,700——37,700Jun 18, 2026Jun 23, 2026 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASE
29,600——121,745Jun 18, 2026Jun 23, 2026 ↗View →
CELC
CELCUITY INC.
PURCHASEGRANT
Gift
14,048——14,048Jun 10, 2026Jun 12, 2026 ↗View →
CELC
CELCUITY INC.
SALEGRANT
Gift
14,048——0Jun 10, 2026Jun 12, 2026 ↗View →
CELC
CELCUITY INC.
PURCHASEGRANT
Stock grant
1,530——6,530Jun 5, 2026Jun 9, 2026 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASE
6,100$4.17$25.4K92,145May 18, 2026May 21, 2026 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
SALE
29,600——0Jun 20, 2025Jun 24, 2025 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
41,200——41,200Jun 20, 2025Jun 24, 2025 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASE
29,600——86,045Jun 20, 2025Jun 24, 2025 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
29,600——29,600Jun 20, 2025Jun 24, 2025 ↗View →
CELC
CELCUITY INC.
SALEGRANT
Gift
8,153——0May 28, 2025May 29, 2025 ↗View →
CELC
CELCUITY INC.
PURCHASEGRANT
Gift
8,153——8,153May 28, 2025May 29, 2025 ↗View →
CELC
CELCUITY INC.
PURCHASEGRANT
Stock grant
14,048——14,048May 19, 2025May 21, 2025 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASE
6,100$4.17$25.4K92,145May 18, 2025May 20, 2026 ↗View →
CELC
CELCUITY INC.
SALEGRANT
Gift
11,645——0Jun 24, 2024May 29, 2025 ↗View →
CELC
CELCUITY INC.
PURCHASEGRANT
Gift
16,300——16,300Jun 24, 2024May 29, 2025 ↗View →
CELC
CELCUITY INC.
SALEGRANT
Gift
16,300——0Jun 24, 2024May 29, 2025 ↗View →
CELC
CELCUITY INC.
PURCHASEGRANT
Gift
11,645——11,645Jun 24, 2024May 29, 2025 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
41,200——41,200Jun 21, 2024Jun 21, 2024 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
29,600——29,600Jun 21, 2024Jun 21, 2024 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
SALE
33,150——0Jun 16, 2024Jun 18, 2024 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASE
33,150——56,445Jun 16, 2024Jun 18, 2024 ↗View →
CELC
CELCUITY INC.
PURCHASEGRANT
Stock grant
8,153——8,153Jun 4, 2024Jun 6, 2024 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
33,150——33,150Jun 16, 2023Jun 21, 2023 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
46,750——46,750Jun 16, 2023Jun 21, 2023 ↗View →
CELC
CELCUITY INC.
PURCHASEGRANT
Stock grant
11,645——11,645May 15, 2023May 17, 2023 ↗View →
CELC
CELCUITY INC.
PURCHASE
5,000$9.68$48.4K5,000Nov 22, 2022Nov 23, 2022 ↗View →
CELC
CELCUITY INC.
PURCHASEGRANT
Stock grant
10,000——10,000Sep 12, 2022Sep 14, 2022 ↗View →
CELC
CELCUITY INC.
PURCHASEGRANT
Stock grant
16,300——16,300Sep 12, 2022Sep 14, 2022 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
61,264——61,264Jun 17, 2022Jun 21, 2022 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASE
12,000$8.57$102.8K23,295Dec 20, 2021Dec 21, 2021 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
34,025——34,025Jun 18, 2021Jun 21, 2021 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
PURCHASE
11,295——11,295Nov 3, 2020Nov 3, 2020 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
SALE
7,122——0Nov 3, 2020Nov 3, 2020 ↗View →
AVIR
ATEA PHARMACEUTICALS, INC.
SALE
4,173——0Nov 3, 2020Nov 3, 2020 ↗View →
Other insiders · CELC
Loading peer insiders…
About this filer
CIK 0001829248
ROLE
Director
PRIMARY
CELC
COMPANIES
2
ACTIVE SINCE
Nov 2020
MARKETPEEL · /INSIDER/0001829248DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback